T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Steel Dynamics
STLD
$37.2B
| $77.7M | 0.01% |
1,328,697
-49,673
| -4% | -$3.17M |
|
852
Tandem Diabetes Care
TNDM
$1.61B
| $77.6M | 0.01% |
650,305
-131,038
| -17% | -$14.4M |
|
853
KE Holdings
BEKE
$18.7B
| $77.4M | 0.01% |
4,236,991
+1,304,812
| +44% | +$31.8M |
|
|
CHUY
854
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $77.3M | 0.01% |
2,452,467
-20,095
| -0.8% | -$658K |
|
855
Paychex
PAYX
$44.6B
| $77.1M | 0.01% |
685,956
-11,402
| -2% | -$1.28M |
|
856
Johnson Controls International
JCI
$91.8B
| $77.1M | 0.01% |
1,132,434
-487,123
| -30% | -$35.2M |
|
857
Regal Rexnord
RRX
$11.3B
| $77M | 0.01% |
512,419
+99,522
| +24% | +$14.3M |
|
858
ADC Therapeutics
ADCT
$132M
| $76.8M | 0.01% |
2,828,740
+166,155
| +6% | +$4.26M |
|
859
Outset Medical
OM
$82.7M
| $76.7M | 0.01% |
103,395
-147,281
| -59% | -$100M |
|
860
Advantage Solutions
ADV
$425M
| $76.6M | 0.01% |
354,350
+13,301
| +4% | +$3.12M |
|
861
Huron Consulting
HURN
$2.47B
| $76.4M | 0.01% |
1,469,413
+254,520
| +21% | +$12.4M |
|
|
SAFM
862
DELISTED
Sanderson Farms Inc
SAFM
| $76.3M | 0.01% |
405,415
-805,566
| -67% | -$152M |
|
863
Voya Financial
VOYA
$9.14B
| $76.1M | 0.01% |
1,239,636
+166,584
| +16% | +$10.6M |
|
|
PRA
864
DELISTED
ProAssurance
PRA
| $76M | 0.01% |
3,196,378
+58,448
| +2% | +$1.35M |
|
865
Carrier Global
CARR
$52.3B
| $75.6M | 0.01% |
1,460,839
+51,368
| +4% | +$2.76M |
|
866
Flowserve
FLS
$10.3B
| $75.6M | 0.01% |
2,180,441
-13,925
| -0.6% | -$545K |
|
867
Hershey
HSY
$37.5B
| $75.5M | 0.01% |
446,319
-31,869
| -7% | -$5.63M |
|
868
Preferred Bank
PFBC
$1.27B
| $75.5M | 0.01% |
1,132,399
-2,514
| -0.2% | -$154K |
|
869
Franklin Resources
BEN
$17.2B
| $75.2M | 0.01% |
2,528,659
-739,027
| -23% | -$23.1M |
|
|
TWTR
870
DELISTED
Twitter, Inc.
TWTR
| $75.1M | 0.01% |
1,244,026
-23,620
| -2% | -$1.55M |
|
871
Maravai LifeSciences
MRVI
$870M
| $75M | 0.01% |
1,528,533
+675,951
| +79% | +$33M |
|
872
NeoGenomics
NEO
$2.11B
| $74.8M | 0.01% |
1,551,502
-7,545
| -0.5% | -$349K |
|
873
Southern Copper
SCCO
$159B
| $74.8M | 0.01% |
1,453,713
-1,497,776
| -51% | -$85.7M |
|
874
Onto Innovation
ONTO
$20.6B
| $74.5M | 0.01% |
1,031,280
+15,315
| +2% | +$1.1M |
|
875
ADT
ADT
$5.45B
| $74.5M | 0.01% |
9,203,167
+25,563
| +0.3% | +$236K |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.